Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Value-Based Cancer Care

- PMLiVE

Biotech now vital to pipelines – but success rates falling

IQVIA picks out key trends to drive future productivity

Havas Lynx shines a spotlight on carers

Manchester based healthcare communications agency, Havas lynx, has launched its annual white paper campaign, which this year promotes the vital need to support the growing number of carers in our...

Havas Lynx

- PMLiVE

FDA approves AbbVie’s psoriasis blockbuster-to-be Skyrizi

Analysts forecast make $1.74bn in 2023

- PMLiVE

Gracell Bio developing faster, cheaper CAR-T production

Manufacturing can be cut from two weeks to one day

- PMLiVE

Alcon spun off, leaner Novartis raises profit forecast

Expects three new launches in 2019

- PMLiVE

Poseida gets Novartis backing for myleoma CAR-T challenger

San Diego firm joins crowded field

Eli Lilly HQ

Lilly invests in antibody oligonucleotides conjugates with Avidity deal

Companies to develop new immonology medicines

The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt

The deal is done. After undoubtedly tense negotiations, the heads of terms for the new Voluntary Scheme for Branded Medicines Pricing and Access have just been published, and although some...

- PMLiVE

Bad news for BMS as Keytruda kidney cancer combo approved

Opdivo and Yervoy combination will be squeezed

- PMLiVE

New biotech accelerator launched in Cambridge, UK

Start Codon aims to invest in 50 start-up companies over the next five years

- PMLiVE

Genfit claims FDA breakthrough status for liver disease drug

Elafibranor up for speedy US review

- PMLiVE

With Spiriva under pressure, Boehringer moves to bolster pipeline

Forges alliance with PureTech Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links